ID   GABT_RAT                Reviewed;         500 AA.
AC   P50554; O70539; Q66HM1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 3.
DT   29-MAY-2024, entry version 175.
DE   RecName: Full=4-aminobutyrate aminotransferase, mitochondrial;
DE            Short=beta-AlaAT I {ECO:0000303|PubMed:10447691};
DE            EC=2.6.1.19 {ECO:0000269|PubMed:10447691};
DE   AltName: Full=(S)-3-amino-2-methylpropionate transaminase;
DE            EC=2.6.1.22 {ECO:0000269|PubMed:10989446};
DE   AltName: Full=GABA aminotransferase;
DE            Short=GABA-AT;
DE   AltName: Full=Gamma-amino-N-butyrate transaminase;
DE            Short=GABA transaminase;
DE            Short=GABA-T;
DE   AltName: Full=L-AIBAT;
DE   Contains:
DE     RecName: Full=4-aminobutyrate aminotransferase, brain isoform {ECO:0000303|PubMed:10447691};
DE   Contains:
DE     RecName: Full=4-aminobutyrate aminotransferase, liver isoform {ECO:0000303|PubMed:10447691};
DE   Flags: Precursor;
GN   Name=Abat {ECO:0000312|RGD:620948}; Synonyms=Gabat;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8133261; DOI=10.1046/j.1471-4159.1994.62041267.x;
RA   Medina-Kauwe L.K., Tillakaratne N.J., Wu J.Y., Tobin A.J.;
RT   "A rat brain cDNA encodes enzymatically active GABA transaminase and
RT   provides a molecular probe for GABA-catabolizing cells.";
RL   J. Neurochem. 62:1267-1275(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 35-54, PROTEOLYTIC
RP   PROCESSING, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Liver;
RX   PubMed=10447691; DOI=10.1046/j.1432-1327.1999.00612.x;
RA   Kontani Y., Sakata S.F., Matsuda K., Ohyama T., Sano K., Tamaki N.;
RT   "The mature size of rat 4-aminobutyrate aminotransferase is different in
RT   liver and brain.";
RL   Eur. J. Biochem. 264:218-222(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=10989446; DOI=10.1016/s0076-6879(00)24247-x;
RA   Tamaki N., Sakata S.F., Matsuda K.;
RT   "Purification, properties, and sequencing of aminoisobutyrate
RT   aminotransferases from rat liver.";
RL   Methods Enzymol. 324:376-389(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 253-268 AND 389-400, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
CC   -!- FUNCTION: Catalyzes the conversion of gamma-aminobutyrate and L-beta-
CC       aminoisobutyrate to succinate semialdehyde and methylmalonate
CC       semialdehyde, respectively (PubMed:10447691). Can also convert delta-
CC       aminovalerate and beta-alanine (PubMed:10447691).
CC       {ECO:0000269|PubMed:10447691, ECO:0000269|PubMed:10989446}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + 4-aminobutanoate = L-glutamate + succinate
CC         semialdehyde; Xref=Rhea:RHEA:23352, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:57706, ChEBI:CHEBI:59888; EC=2.6.1.19;
CC         Evidence={ECO:0000269|PubMed:10447691, ECO:0000269|PubMed:10989446};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23353;
CC         Evidence={ECO:0000305|PubMed:10447691, ECO:0000305|PubMed:10989446};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-3-amino-2-methylpropanoate + 2-oxoglutarate = 2-methyl-3-
CC         oxopropanoate + L-glutamate; Xref=Rhea:RHEA:13993, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:57700, ChEBI:CHEBI:58655; EC=2.6.1.22;
CC         Evidence={ECO:0000269|PubMed:10989446};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13994;
CC         Evidence={ECO:0000305|PubMed:10989446};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250|UniProtKB:P80147};
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:190135;
CC         Evidence={ECO:0000250|UniProtKB:P80147};
CC       Note=Binds 1 [2Fe-2S] cluster per homodimer.
CC       {ECO:0000250|UniProtKB:P80147};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES: [4-aminobutyrate aminotransferase, liver isoform]:
CC       Kinetic parameters:
CC         KM=1.6 mM for 4-aminobutanoate {ECO:0000269|PubMed:10447691};
CC         KM=5.3 mM for beta-alanine {ECO:0000269|PubMed:10447691};
CC         Vmax=0.83 umol/min/mg enzyme {ECO:0000269|PubMed:10447691};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES: [4-aminobutyrate aminotransferase, brain isoform]:
CC       Kinetic parameters:
CC         KM=1.6 mM for 4-aminobutanoate {ECO:0000269|PubMed:10447691};
CC         KM=6.1 mM for beta-alanine {ECO:0000269|PubMed:10447691};
CC         Vmax=1 umol/min/mg enzyme {ECO:0000269|PubMed:10447691};
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000305|PubMed:10447691}.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U29701; AAA70415.1; -; mRNA.
DR   EMBL; D87839; BAA25570.1; -; mRNA.
DR   EMBL; BC081787; AAH81787.1; -; mRNA.
DR   PIR; I56502; I56502.
DR   RefSeq; NP_112265.1; NM_031003.2.
DR   RefSeq; XP_006245822.1; XM_006245760.3.
DR   AlphaFoldDB; P50554; -.
DR   SMR; P50554; -.
DR   BioGRID; 249532; 1.
DR   IntAct; P50554; 1.
DR   MINT; P50554; -.
DR   STRING; 10116.ENSRNOP00000003633; -.
DR   BindingDB; P50554; -.
DR   ChEMBL; CHEMBL3148; -.
DR   DrugCentral; P50554; -.
DR   iPTMnet; P50554; -.
DR   PhosphoSitePlus; P50554; -.
DR   SwissPalm; P50554; -.
DR   jPOST; P50554; -.
DR   PaxDb; 10116-ENSRNOP00000003633; -.
DR   Ensembl; ENSRNOT00000003633.5; ENSRNOP00000003633.2; ENSRNOG00000002636.8.
DR   Ensembl; ENSRNOT00055043768; ENSRNOP00055035754; ENSRNOG00055025368.
DR   Ensembl; ENSRNOT00060017651; ENSRNOP00060013718; ENSRNOG00060010424.
DR   Ensembl; ENSRNOT00065004124; ENSRNOP00065002944; ENSRNOG00065002947.
DR   GeneID; 81632; -.
DR   KEGG; rno:81632; -.
DR   UCSC; RGD:620948; rat.
DR   AGR; RGD:620948; -.
DR   CTD; 18; -.
DR   RGD; 620948; Abat.
DR   eggNOG; KOG1405; Eukaryota.
DR   GeneTree; ENSGT00550000074885; -.
DR   HOGENOM; CLU_016922_12_1_1; -.
DR   InParanoid; P50554; -.
DR   OMA; KTQVCGI; -.
DR   OrthoDB; 177625at2759; -.
DR   PhylomeDB; P50554; -.
DR   TreeFam; TF105021; -.
DR   BRENDA; 2.6.1.19; 5301.
DR   Reactome; R-RNO-916853; Degradation of GABA.
DR   SABIO-RK; P50554; -.
DR   PRO; PR:P50554; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000002636; Expressed in liver and 15 other cell types or tissues.
DR   GO; GO:0032144; C:4-aminobutyrate transaminase complex; ISS:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0047298; F:(S)-3-amino-2-methylpropionate transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003867; F:4-aminobutyrate transaminase activity; IDA:RGD.
DR   GO; GO:0034386; F:4-aminobutyrate:2-oxoglutarate transaminase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; ISS:UniProtKB.
DR   GO; GO:0032145; F:succinate-semialdehyde dehydrogenase binding; ISS:UniProtKB.
DR   GO; GO:0048148; P:behavioral response to cocaine; ISS:UniProtKB.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0007620; P:copulation; IMP:RGD.
DR   GO; GO:0035640; P:exploration behavior; IMP:RGD.
DR   GO; GO:0009449; P:gamma-aminobutyric acid biosynthetic process; IMP:RGD.
DR   GO; GO:0009450; P:gamma-aminobutyric acid catabolic process; IBA:GO_Central.
DR   GO; GO:0009448; P:gamma-aminobutyric acid metabolic process; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; IMP:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IMP:RGD.
DR   GO; GO:0033602; P:negative regulation of dopamine secretion; IMP:RGD.
DR   GO; GO:0014053; P:negative regulation of gamma-aminobutyric acid secretion; IMP:RGD.
DR   GO; GO:1904450; P:positive regulation of aspartate secretion; IMP:RGD.
DR   GO; GO:0045964; P:positive regulation of dopamine metabolic process; IMP:RGD.
DR   GO; GO:0031652; P:positive regulation of heat generation; IMP:RGD.
DR   GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; IMP:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:1902722; P:positive regulation of prolactin secretion; IMP:RGD.
DR   GO; GO:0070474; P:positive regulation of uterine smooth muscle contraction; IMP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IMP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IMP:RGD.
DR   GO; GO:0010039; P:response to iron ion; IDA:RGD.
DR   GO; GO:0035094; P:response to nicotine; IMP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   CDD; cd00610; OAT_like; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR004631; 4NH2But_aminotransferase_euk.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR049704; Aminotrans_3_PPA_site.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   NCBIfam; TIGR00699; GABAtrns_euk; 1.
DR   PANTHER; PTHR43206:SF1; 4-AMINOBUTYRATE AMINOTRANSFERASE, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43206; AMINOTRANSFERASE; 1.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   PIRSF; PIRSF000521; Transaminase_4ab_Lys_Orn; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminotransferase; Direct protein sequencing; Disulfide bond;
KW   Iron; Iron-sulfur; Metal-binding; Mitochondrion;
KW   Neurotransmitter degradation; Pyridoxal phosphate; Reference proteome;
KW   Transferase; Transit peptide.
FT   TRANSIT         1..27
FT                   /note="Mitochondrion"
FT   CHAIN           28..500
FT                   /note="4-aminobutyrate aminotransferase, brain isoform"
FT                   /evidence="ECO:0000303|PubMed:10447691"
FT                   /id="PRO_0000001252"
FT   CHAIN           35..500
FT                   /note="4-aminobutyrate aminotransferase, liver isoform"
FT                   /evidence="ECO:0000303|PubMed:10447691"
FT                   /id="PRO_0000001253"
FT   BINDING         163
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P80147"
FT   BINDING         164..165
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:P80147"
FT   BINDING         166
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P80147"
FT   BINDING         220
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P80147"
FT   BINDING         381
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P80147"
FT   MOD_RES         231
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         252
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         252
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         279
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         318
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         357
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P80147"
FT   MOD_RES         413
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         413
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         452
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   MOD_RES         470
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61922"
FT   DISULFID        321
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        3
FT                   /note="F -> L (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        25
FT                   /note="S -> T (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        36
FT                   /note="D -> T (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135..170
FT                   /note="PPENFVDKLRESLMSVAPKGMCQLITMACGSCSNEN -> LQRTLWTSSGSP
FT                   CSRWLPKACVSSSRWPAGPAPMRM (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        277
FT                   /note="I -> N (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        425
FT                   /note="Q -> R (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        447
FT                   /note="E -> K (in Ref. 2 and 3; BAA25570)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        486
FT                   /note="H -> Q (in Ref. 1; AAA70415)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   500 AA;  56456 MW;  1EA7180B72797B72 CRC64;
     MAFLLTTRRL VCSSQKNLHL FTPGSRYISQ AAAKVDFEFD YDGPLMKTEV PGPRSQELMK
     QLNTIQNAEA VHFFCNYEES RGNYLVDVDG NRMLDLYSQI SSVPIGYNHP ALAKLVQQPQ
     NASTFINRPA LGILPPENFV DKLRESLMSV APKGMCQLIT MACGSCSNEN AFKTIFMWYR
     SKERGQRGFS KEELETCMVN QSPGCPDYSI LSFMGAFHGR TMGCLATTHS KAIHKIDIPS
     FDWPIAPFPR LKYPLEEFVT DNQQEEARCL EEVEDLIVKY RKKKRTVAGI IVEPIQSEGG
     DNHASDDFFR KLRDIARKHG CAFLVDEVQT GGGCTGKFWA HEHWGLDDPA DVMSFSKKMM
     TGGFFHKEEF RPSAPYRIFN TWLGDPSKNL LLAEVINIIK REDLLNNVAH AGKTLLTGLL
     DLQAQYPQFV SRVRGRGTFC SFDTPDEAIR NKLILIARNK GVVLGGCGDK SIRFRPTLVF
     RDHHAHLFLN IFSGILADFK
//
